Merck KGaA to Invest Around $465 Million to Expand Operations in Ireland
23 Maio 2022 - 6:53AM
Dow Jones News
By Cecilia Butini
Merck KGaA said Monday that it would invest about 440 million
euros ($464.8 million) to expand manufacturing in membrane and
filtration, as part of its life-science business, in Ireland.
The German pharmaceuticals and chemicals company said the
investment is to increase membrane-manufacturing capacity in
Carrigtwohill and to build a new site for filtration manufacture at
Blarney Business Park. Both facilities are going to be in Cork.
"Ireland is central to our strategy to drive long-term growth
and expand our global leadership position in Life Science," said
Matthias Heinzel, chief executive of Merck's Life Science business,
which is one of the company's growth drivers.
Membrane production is also set to benefit the company's Process
Solutions business, another key growth driver for Merck, the
company said.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
May 23, 2022 05:38 ET (09:38 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Merck KGAA (TG:MRK)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Merck KGAA (TG:MRK)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024